Emerging role of antibiotics in atherosclerosis

American Heart Journal

Volumn 138, Issue 5 II, 1999, Pages

  Gurfinkel, E P ^a   Bozovich, G ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ROXITHROMYCIN;

ANTIBIOTIC THERAPY; ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL;

EID: 0032738820     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70295-4     Document Type: Conference Paper

References (21)

1. Gurfinkel E, on behalf of the principal contributors. Current treatment and future prospects for the management of acute coronary syndromes. Consensus Recommendation of the 1997 Ushuaia Conference. Tierra del Fuego, Argentina. Clin Drug Invest 1998;15:368-80.
2. Gurfinkel E, Fareed J, Antman E, et al. The rationale for the management of acute coronary syndromes with low molecular weight heparins. Am J Cardiol 1998;82:15L-18L.
3. Oler A, Whooley MA, Oler J, et al. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: a meta-analysis. JAMA 1996;276:811-5.
4. Shomig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996;334:1084-9.
5. TIMI IIIb Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIb trial. Circulation 1994;89:1545-6.
6. Boden WE, O'Rourke RA, Crawford MH, et al. For the Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators: outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative strategy. N Engl J Med 1998;338:1785-92.
7. Dirksen MT, van der Wal AC, van den Berg FM, et al. Distribution of inflammatory cells in atherosclerotic plaques relates to the direction of flow. Circulation 1998;98:2000-3.
8. Gurfinkel E, Bozovich G. Chlamydia pneumoniae, inflammation and the instability of the atherosclerotic plaque. Atherosclerosis 1998;140(suppl 1):S31-5.
9. Gurfinkel E, Scirica B, Bozovich G, et al. Serum neopterin levels and the aggressiveness of atherosclerosis. Am J Cardiol 1999;83:515-8.
10. Gurfinkel E, Bozovich G, Daroca A, et al, for the ROXIS Study Group. Randomised study: ROXIS pilot study, roxithromycin in non-Q-wave coronary syndromes. Lancet 1997;350:404-7.
11. Gurfinkel E, Bozovich G, Livellara G, et al. Antibiotics for the treatment of non Q wave coronary syndromes: the final report of the ROXIS trial. Eur Heart J 1999;20:121-7.
12. Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azythromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
13. Anderson J, Muhlenstein JB. Azythromycin in coronary artery disease: elimination of myocardial infection with Chlamydia (ACADEMIC). Presented at the American College of Cardiology Annual Scientific Sessions, Atlanta, Ga, March 31, 1998.
14. Anestad G, Scheel O, Hungnes O. Chronic infection and coronary artery disease. Lancet 1997;350:1028.
15. Saikku P, Leinonen M, Mattila K. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-5.
16. Gurfinkel E, Rozlosnik J, Bozovich G, et al. IgG antibodies to chlamydial and mycoplasma infection plus C-reactive protein related to poor clinical outcome in unstable angina. Arch Inst Cardiol Mex 1997;67:462-8.
17. Muhlestein JB, Hammond EH, Carlquist JF, et al. Increased incidence of chlamydia species within the coronary arteries of patients with symptomatic atherosclerosis versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-61.
18. Fong IW, Chiu B, Viira E, et al. Rabbit model for Chlamydia pneumoniae infection. J Clin Microb 1997;35:48-52.
19. Muhlenstein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
20. Kol A, Sukhova GK, Lichtman AH, et al. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998;98:300-7.
21. Gurfinkel E. Antibiotic to stabilize vulnerable plaque. In: Brown DL, editor. Cardiovascular Plaque rupture. Marcel Dekker, Inc, New York, NY; In press.